Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association
-
Saudi J Gastroenterol · Nov 2014
Randomized Controlled Trial Multicenter StudyEfficacy and safety of drotaverine hydrochloride in irritable bowel syndrome: a randomized double-blind placebo-controlled study.
To study the efficacy and safety of drotaverine hydrochloride (HCl) 80 mg tablet given thrice a day in the symptomatic relief of patients with irritable bowel syndrome (IBS). ⋯ A 4-week treatment with drotaverine significantly improves abdominal symptoms in patients with IBS.